Design Therapeutics's total assets for Q4 2024 were $252.09M, a decrease of -3.64% from the previous quarter. DSGN total liabilities were $10.00M for the fiscal quarter, a 8.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.